Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 119 | 141↑18.3% | 214↑52.1% | 398↑85.9% | 492↑23.5% |
| Gross Profit | 102 | 119↑16.6% | 180↑51.2% | 346↑92.6% | 423↑22.1% |
| Operating Income | 41 | 52↑26.8% | 102↑94.4% | 87↓14.8% | 195↑124.8% |
| Net Income | 75 | 39↓47.3% | 83↑110.4% | 71↓14.0% | 164↑129.5% |
| EBITDA | 41 | 53↑27.0% | 103↑96.0% | 120↑16.1% | 233↑94.6% |
| EPS Diluted | 0.71 | 0.37↓47.9% | 0.75↑102.7% | 0.63↓16.0% | 1.31↑107.9% |